Restoration of positioning control following Disabled-2 expression in ovarian and breast tumor cells.
about
Disabled-2 (Dab2) is required for transforming growth factor beta-induced epithelial to mesenchymal transition (EMT)Quantitative proteomics identifies a Dab2/integrin module regulating cell migrationDisabled-2 (Dab2) inhibits Wnt/β-catenin signalling by binding LRP6 and promoting its internalization through clathrinDisabled-2 exhibits the properties of a cargo-selective endocytic clathrin adaptorDual roles for the Dab2 adaptor protein in embryonic development and kidney transportGATA-4 and GATA-5 transcription factor genes and potential downstream antitumor target genes are epigenetically silenced in colorectal and gastric cancerMicroarray comparative genomic hybridization detection of chromosomal imbalances in uterine cervix carcinoma.Frequent loss expression of dab2 and promotor hypermethylation in human cancers: a meta-analysis and systematic reviewStructure, sulfatide binding properties, and inhibition of platelet aggregation by a disabled-2 protein-derived peptide.Endocytosis and Physiology: Insights from Disabled-2 Deficient MiceCell cycle-dependent phosphorylation of Disabled-2 by cdc2miR-145 is differentially regulated by TGF-β1 and ischaemia and targets Disabled-2 expression and wnt/β-catenin activitySulfatides partition disabled-2 in response to platelet activation.Transcription profiles of non-immortalized breast cancer cell lines.Loss of GATA4 and GATA6 expression specifies ovarian cancer histological subtypes and precedes neoplastic transformation of ovarian surface epitheliaAtypical PKCiota contributes to poor prognosis through loss of apical-basal polarity and cyclin E overexpression in ovarian cancer.Loss of disabled-2 expression is an early event in esophageal squamous tumorigenesis.Development of c-MET pathway inhibitors.Hormonal induction and roles of Disabled-2 in lactation and involution.Differential requirement for Dab2 in the development of embryonic and extra-embryonic tissues.Disabled-2 heterozygous mice are predisposed to endometrial and ovarian tumorigenesis and exhibit sex-biased embryonic lethality in a p53-null backgroundAltered renal proximal tubular endocytosis and histology in mice lacking myosin-VI.Genes responsive to both oxidant stress and loss of estrogen receptor function identify a poor prognosis group of estrogen receptor positive primary breast cancers.Overexpression of RhoA induces preneoplastic transformation of primary mammary epithelial cells.Endocytic proteins in the regulation of nuclear signaling, transcription and tumorigenesis.Disabled homolog 2 is required for migration and invasion of prostate cancer cells.Aberrant promoter methylation of Dab2 gene in myelodysplastic syndrome.Histone modifications silence the GATA transcription factor genes in ovarian cancer.Disabled-2 mediates c-Fos suppression and the cell growth regulatory activity of retinoic acid in embryonic carcinoma cells.C-Fos elimination compensates for disabled-2 requirement in mouse extraembryonic endoderm developmentDisassociation of MAPK activation and c-Fos expression in F9 embryonic carcinoma cells following retinoic acid-induced endoderm differentiation.Ras/MAPK pathway confers basement membrane dependence upon endoderm differentiation of embryonic carcinoma cells.Dynamic alterations of the extracellular environment of ovarian surface epithelial cells in premalignant transformation, tumorigenicity, and metastasis.
P2860
Q24296708-B0F82381-3086-4062-BE55-B085D44E2778Q24311541-D06E45E2-F264-460D-8732-916E56D4F146Q24312151-FA3F4DB1-AAA5-4AD7-9E99-504C2DF681CDQ24534474-E9101489-F82F-4875-94E8-9690A0584918Q24536278-96C34768-ACD3-4CB4-98A5-948D766BA37BQ24648331-74DA265C-2D67-438C-B877-5E9DE5477C4BQ24813298-FC855A28-0B4A-4B74-832E-D21E75E33BDFQ27002445-10A2EEF9-8128-4384-863D-FB3C65022674Q27673101-1480FB80-0940-48B6-A1F4-AD066CA5B418Q28076375-59F96C01-6CEA-4450-B053-D72D7EA62220Q28189608-BE9EE029-5610-43F2-BFE7-F1B5981DCDE0Q28573942-EFE2E9F4-2704-4364-91F0-12579D6C8887Q30942858-6747C55F-298E-4123-8D66-A105AD0A6A72Q33240474-3FE7D485-2713-42D3-8527-4638D16B0027Q33489525-EBADABD1-B53D-44B5-A7CE-294FA183D2F6Q33920769-DC1885D8-D7F3-4950-B072-522C0C1CBF0EQ34013092-90D2B577-9B64-4EBB-BF09-25BE73B1E185Q34198905-A7B862CD-A070-4370-AAE1-A3D51F81422EQ34434655-80863BC3-BF52-4DF1-A253-B75E7350F3A0Q35028025-7CC7D98E-7856-4081-A879-E09050BF992AQ35221856-E696B757-8C1A-4EB8-AB53-731E4479022FQ36308909-2E095B3E-EDB6-4FC8-B792-8328DBB6DF01Q36955094-E38A1E95-02D1-4315-8B4C-5F5D2E7B985DQ37473906-47CCF5B0-21FC-4E1C-8FD0-234D898A2BD5Q37541507-4C166051-14CB-47E0-AB8D-8E746896E04DQ38856672-36A7ED07-4435-4A51-8893-8E2C713EC18BQ39272984-91AEC4E0-094E-4C98-BFE1-CEDE781B1F40Q40293973-A3DDAB30-8912-4968-B10F-6B3DE75F2DFCQ40778012-7A91F28F-8554-4889-897A-EF167E7760B1Q42082781-783EAD81-3138-43F4-AD00-C730D09E227CQ43636975-A481746F-CEDB-4C67-8928-5AE61A9B7B38Q44081163-CB791AB7-9263-4141-AE52-4D767BF6D0C8Q52831286-AEB6FE56-8227-47F7-9912-98E7359A6565
P2860
Restoration of positioning control following Disabled-2 expression in ovarian and breast tumor cells.
description
2000 nî lūn-bûn
@nan
2000 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Restoration of positioning con ...... varian and breast tumor cells.
@ast
Restoration of positioning con ...... varian and breast tumor cells.
@en
type
label
Restoration of positioning con ...... varian and breast tumor cells.
@ast
Restoration of positioning con ...... varian and breast tumor cells.
@en
prefLabel
Restoration of positioning con ...... varian and breast tumor cells.
@ast
Restoration of positioning con ...... varian and breast tumor cells.
@en
P2093
P2860
P356
P1433
P1476
Restoration of positioning con ...... varian and breast tumor cells.
@en
P2093
P2860
P2888
P304
P356
10.1038/SJ.ONC.1203853
P407
P577
2000-10-01T00:00:00Z
P5875
P6179
1031290176